Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Feb;36(2):97–102.

A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer

N Froggatt 1, J Green 1, C Brassett 1, D Evans 1, D Bishop 1, R Kolodner 1, E Maher 1
PMCID: PMC1734294  PMID: 10051005

Abstract

The frequency, origin, and phenotypic expression of a germline MSH2 gene mutation previously identified in seven kindreds with hereditary non-polyposis cancer syndrome (HNPCC) was investigated. The mutation (A→T at nt943+3) disrupts the 3' splice site of exon 5 leading to the deletion of this exon from MSH2 mRNA and represents the only frequent MSH2 mutation so far reported. Although this mutation was initially detected in four of 33 colorectal cancer families analysed from eastern England, more extensive analysis has reduced the frequency to four of 52 (8%) English HNPCC kindreds analysed. In contrast, the MSH2 mutation was identified in 10 of 20 (50%) separately identified colorectal families from Newfoundland. To investigate the origin of this mutation in colorectal cancer families from England (n=4), Newfoundland (n=10), and the United States (n=3), haplotype analysis using microsatellite markers linked to MSH2 was performed. Within the English and US families there was little evidence for a recent common origin of the MSH2 splice site mutation in most families. In contrast, a common haplotype was identified at the two flanking markers (CA5 and D2S288) in eight of the Newfoundland families. These findings suggested a founder effect within Newfoundland similar to that reported by others for two MLH1 mutations in Finnish HNPCC families. We calculated age related risks of all, colorectal, endometrial, and ovarian cancers in nt943+3 A→T MSH2 mutation carriers (n=76) for all patients and for men and women separately. For both sexes combined, the penetrances at age 60 years for all cancers and for colorectal cancer were 0.86 and 0.57, respectively. The risk of colorectal cancer was significantly higher (p<0.01) in males than females (0.63 v 0.30 and 0.84 v 0.44 at ages 50 and 60 years, respectively). For females there was a high risk of endometrial cancer (0.5 at age 60 years) and premenopausal ovarian cancer (0.2 at 50 years). These intersex differences in colorectal cancer risks have implications for screening programmes and for attempts to identify colorectal cancer susceptibility modifiers.


Keywords: MSH2 mutation; HNPCC; colorectal cancer

Full Text

The Full Text of this article is available as a PDF (143.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarnio M., Mecklin J. P., Aaltonen L. A., Nyström-Lahti M., Järvinen H. J. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer. 1995 Dec 20;64(6):430–433. doi: 10.1002/ijc.2910640613. [DOI] [PubMed] [Google Scholar]
  2. Bronner C. E., Baker S. M., Morrison P. T., Warren G., Smith L. G., Lescoe M. K., Kane M., Earabino C., Lipford J., Lindblom A. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 1994 Mar 17;368(6468):258–261. doi: 10.1038/368258a0. [DOI] [PubMed] [Google Scholar]
  3. Buerstedde J. M., Alday P., Torhorst J., Weber W., Müller H., Scott R. Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes. J Med Genet. 1995 Nov;32(11):909–912. doi: 10.1136/jmg.32.11.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dunlop M. G., Farrington S. M., Carothers A. D., Wyllie A. H., Sharp L., Burn J., Liu B., Kinzler K. W., Vogelstein B. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997 Jan;6(1):105–110. doi: 10.1093/hmg/6.1.105. [DOI] [PubMed] [Google Scholar]
  5. Fishel R., Lescoe M. K., Rao M. R., Copeland N. G., Jenkins N. A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993 Dec 3;75(5):1027–1038. doi: 10.1016/0092-8674(93)90546-3. [DOI] [PubMed] [Google Scholar]
  6. Froggatt N. J., Joyce J. A., Davies R., Gareth D., Evans R., Ponder B. A., Barton D. E., Maher E. R. A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome. Lancet. 1995 Mar 18;345(8951):727–727. doi: 10.1016/s0140-6736(95)90900-1. [DOI] [PubMed] [Google Scholar]
  7. Froggatt N. J., Koch J., Davies R., Evans D. G., Clamp A., Quarrell O. W., Weissenbach J., Hodgson S. V., Ponder B. A., Barton D. E. Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome. J Med Genet. 1995 May;32(5):352–357. doi: 10.1136/jmg.32.5.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Généthon human genetic linkage map. Nat Genet. 1994 Jun;7(2 Spec No):246–339. doi: 10.1038/ng0694supp-246. [DOI] [PubMed] [Google Scholar]
  9. Leach F. S., Nicolaides N. C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomäki P., Sistonen P., Aaltonen L. A., Nyström-Lahti M. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 1993 Dec 17;75(6):1215–1225. doi: 10.1016/0092-8674(93)90330-s. [DOI] [PubMed] [Google Scholar]
  10. Liu B., Parsons R. E., Hamilton S. R., Petersen G. M., Lynch H. T., Watson P., Markowitz S., Willson J. K., Green J., de la Chapelle A. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res. 1994 Sep 1;54(17):4590–4594. [PubMed] [Google Scholar]
  11. Liu B., Parsons R., Papadopoulos N., Nicolaides N. C., Lynch H. T., Watson P., Jass J. R., Dunlop M., Wyllie A., Peltomäki P. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med. 1996 Feb;2(2):169–174. doi: 10.1038/nm0296-169. [DOI] [PubMed] [Google Scholar]
  12. Luce M. C., Marra G., Chauhan D. P., Laghi L., Carethers J. M., Cherian S. P., Hawn M., Binnie C. G., Kam-Morgan L. N., Cayouette M. C. In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology. 1995 Oct;109(4):1368–1374. doi: 10.1016/0016-5085(95)90600-2. [DOI] [PubMed] [Google Scholar]
  13. Lynch H. T., Lanspa S., Smyrk T., Boman B., Watson P., Lynch J. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. Cancer Genet Cytogenet. 1991 Jun;53(2):143–160. doi: 10.1016/0165-4608(91)90093-a. [DOI] [PubMed] [Google Scholar]
  14. Lynch H. T., Lynch J. F. The Lynch syndromes. Curr Opin Oncol. 1993 Jul;5(4):687–696. doi: 10.1097/00001622-199307000-00013. [DOI] [PubMed] [Google Scholar]
  15. Miyaki M., Konishi M., Muraoka M., Kikuchi-Yanoshita R., Tanaka K., Iwama T., Mori T., Koike M., Ushio K., Chiba M. Germ line mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary nonpolyposis colorectal cancer (HNPCC): usefulness of DNA analysis for screening and diagnosis of HNPCC patients. J Mol Med (Berl) 1995 Oct;73(10):515–520. doi: 10.1007/BF00198903. [DOI] [PubMed] [Google Scholar]
  16. Moisio A. L., Sistonen P., Weissenbach J., de la Chapelle A., Peltomäki P. Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer. Am J Hum Genet. 1996 Dec;59(6):1243–1251. [PMC free article] [PubMed] [Google Scholar]
  17. Nicolaides N. C., Papadopoulos N., Liu B., Wei Y. F., Carter K. C., Ruben S. M., Rosen C. A., Haseltine W. A., Fleischmann R. D., Fraser C. M. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994 Sep 1;371(6492):75–80. doi: 10.1038/371075a0. [DOI] [PubMed] [Google Scholar]
  18. Nyström-Lahti M., Kristo P., Nicolaides N. C., Chang S. Y., Aaltonen L. A., Moisio A. L., Järvinen H. J., Mecklin J. P., Kinzler K. W., Vogelstein B. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med. 1995 Nov;1(11):1203–1206. doi: 10.1038/nm1195-1203. [DOI] [PubMed] [Google Scholar]
  19. Nyström-Lahti M., Parsons R., Sistonen P., Pylkkänen L., Aaltonen L. A., Leach F. S., Hamilton S. R., Watson P., Bronson E., Fusaro R. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet. 1994 Oct;55(4):659–665. [PMC free article] [PubMed] [Google Scholar]
  20. Nyström-Lahti M., Sistonen P., Mecklin J. P., Pylkkänen L., Aaltonen L. A., Järvinen H., Weissenbach J., de la Chapelle A., Peltomäki P. Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6054–6058. doi: 10.1073/pnas.91.13.6054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Papadopoulos N., Nicolaides N. C., Wei Y. F., Ruben S. M., Carter K. C., Rosen C. A., Haseltine W. A., Fleischmann R. D., Fraser C. M., Adams M. D. Mutation of a mutL homolog in hereditary colon cancer. Science. 1994 Mar 18;263(5153):1625–1629. doi: 10.1126/science.8128251. [DOI] [PubMed] [Google Scholar]
  22. Peltomäki P., Aaltonen L. A., Sistonen P., Pylkkänen L., Mecklin J. P., Järvinen H., Green J. S., Jass J. R., Weber J. L., Leach F. S. Genetic mapping of a locus predisposing to human colorectal cancer. Science. 1993 May 7;260(5109):810–812. doi: 10.1126/science.8484120. [DOI] [PubMed] [Google Scholar]
  23. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Phelan C. M., Rebbeck T. R., Weber B. L., Devilee P., Ruttledge M. H., Lynch H. T., Lenoir G. M., Stratton M. R., Easton D. F., Ponder B. A. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet. 1996 Mar;12(3):309–311. doi: 10.1038/ng0396-309. [DOI] [PubMed] [Google Scholar]
  25. Vasen H. F., Wijnen J. T., Menko F. H., Kleibeuker J. H., Taal B. G., Griffioen G., Nagengast F. M., Meijers-Heijboer E. H., Bertario L., Varesco L. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology. 1996 Apr;110(4):1020–1027. doi: 10.1053/gast.1996.v110.pm8612988. [DOI] [PubMed] [Google Scholar]
  26. Viel A., Genuardi M., Capozzi E., Leonardi F., Bellacosa A., Paravatou-Petsotas M., Pomponi M. G., Fornasarig M., Percesepe A., Roncucci L. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer. 1997 Jan;18(1):8–18. doi: 10.1002/(sici)1098-2264(199701)18:1<8::aid-gcc2>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  27. Watson P., Vasen H. F., Mecklin J. P., Järvinen H., Lynch H. T. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med. 1994 Jun;96(6):516–520. doi: 10.1016/0002-9343(94)90091-4. [DOI] [PubMed] [Google Scholar]
  28. Wijnen J., Khan P. M., Vasen H., Menko F., van der Klift H., van den Broek M., van Leeuwen-Cornelisse I., Nagengast F., Meijers-Heijboer E. J., Lindhout D. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet. 1996 Feb;58(2):300–307. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES